Lucas S. Chang is a partner in Morgan Lewis's Business and Finance Practice and the Managing Partner and chief representative of the firm's Beijing office. As the senior partner of Morgan Lewis's firmwide Greater China Practice, he spends the majority of his time in China, Taiwan and Hong Kong, using the Beijing office as his home base, but also travels on demand to other offices and client sites worldwide.

Dr. Chang was listed among the Top 10 in Northern California Emerging Business and Venture Capital, The Legal 500 (2009), was awarded Morgan, Lewis & Bockius LLP Chairman's Award in 2010, and was listed in the International Who's Who of Life Science Lawyers 2013 (Transactional Section).

Dr. Chang focuses his practice on corporate and securities transactions including foreign direct investment, mergers and acquisitions, venture capital financing, private equity investments, and public offerings, and has handled a variety of cross-border transactions involving complex international corporate structures and special contractual arrangements designed to comply with unique legal requirements in various jurisdictions. A licensed U.S. patent attorney, Dr. Chang has prosecuted many patent applications, provided counseling on IP creation, protection and litigation to international clients, and served as the business/IP interface in several major IP litigation matters. He is also experienced in competition-related legal issues, and has participated in a number of U.S. and EU antitrust investigation and litigation matters. Dr. Chang's clients have included multinational corporations and emerging companies located in the U.S., China, Hong Kong and Taiwan in a variety of sectors such as semiconductor, electronics, computer hardware and software, internet and e-commerce, media and English education, chemicals, energy, and biotechnology and health care.